COLOMYCIN

This brand name is authorized in Estonia, Hong Kong SAR China, Ireland, Lithuania, UK.

Active ingredients

The drug COLOMYCIN contains one active pharmaceutical ingredient (API):

1	Colistimethate UNII XW0E5YS77G - COLISTIMETHATE SODIUM
	Colistimethate is a cyclic polypeptide antibacterial active substance that is derived from Bacillus polymyxa var colistinus and belongs to the polymyxin group. Polymyxins work by damaging the cell membrane and the resulting physiological effects are lethal to the bacterium. Polymyxins are selective for Gram-negative bacteria that have a hydrophobic outer membrane.
	Read more about Colistimethate

Medication package inserts

Below package inserts are available for further reading:

Document	Type	Information Source
COLOMYCIN Powder for solution for injection / infusion / inhalation	MPI, EU: SmPC	Medicines & Healthcare Products Regulatory Agency (GB)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
J01XB01	Colistin	J Antiinfectives for systemic use → J01 Antibacterials for systemic use → J01X Other antibacterials → J01XB Polymyxins
Discover more medicines within J01XB01

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
EE	Ravimiamet	1218125, 1665121, 1737806, 1887453
GB	Medicines & Healthcare Products Regulatory Agency	31087, 46215
HK	Department of Health Drug Office	58514
IE	Health Products Regulatory Authority	66001, 66030, 66035, 66036
LT	Valstybinė vaistų kontrolės tarnyba	1089841, 1090637